These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 578918)

  • 1. The effect of intracerebral injection of cycloheximide on brain protein synthesis and on the hyperactivity syndrome produced by a monoamine oxidase inhibitor and tryptophan.
    Mellanby J
    Neuropharmacology; 1977; 16(7-8):541-4. PubMed ID: 578918
    [No Abstract]   [Full Text] [Related]  

  • 2. The prevention by inhibitors of brain proptein synthesis of the hyperactivity and hyperpyrexia produced in rats by monoamine oxidase inhibition and the administration of L-tryptophan or 5-methoxy-N,N-dimethyltryptamine.
    Grahame-Smith DG
    J Neurochem; 1972 Oct; 19(10):2409-22. PubMed ID: 4512286
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of inhibitors of protein synthesis to inhibit brain protein synthesis and prevent the hyperactivity and hyperpyrexia in rats produced by inhibition of monoamine oxidase and the administration of L-tryptophan or 5-methoxy-NN-dimethyltryptamine.
    Grahame-Smith DG
    Biochem J; 1972 Apr; 127(2):7P. PubMed ID: 5076688
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: The role of brain dopamine in the hyperactivity syndrome produced in rats after administration of L-tryptophan and a monoamine oxidase inhibitor.
    Grahame-Smith DG; Green AR
    Br J Pharmacol; 1974 Mar; 50(3):442P-443P. PubMed ID: 4853875
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG; Green AR
    Br J Pharmacol; 1974 Sep; 52(1):19-26. PubMed ID: 4281339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for brain protein in the process by which brain serotonin and certain other indolealkylamines produce behaviourally excitant effects in the rat.
    Grahame-Smith DG
    Clin Sci; 1972 Feb; 42(2):11P-12P. PubMed ID: 5058563
    [No Abstract]   [Full Text] [Related]  

  • 8. Centrally administered cycloheximide in rats: behavioural concomitants and modulation of amnesic effects by biogenic amines.
    Day TA; Overstreet DH; Schiller GD
    Pharmacol Biochem Behav; 1977 May; 6(5):557-65. PubMed ID: 561408
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor.
    Grahame-Smith DG
    Br J Pharmacol; 1971 Dec; 43(4):856-64. PubMed ID: 4261561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.
    Grahame-Smith DG
    J Neurochem; 1971 Jun; 18(6):1053-66. PubMed ID: 4254940
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats.
    Green AR; Grahame-Smith DG
    Neuropharmacology; 1974 Nov; 13(10-11):949-59. PubMed ID: 4437730
    [No Abstract]   [Full Text] [Related]  

  • 12. Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa.
    Heal DJ; Green AR; Boullin DJ; Grahame-Smith DG
    Psychopharmacology (Berl); 1976 Sep; 49(3):287-300. PubMed ID: 12527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How important is the synthesis of brain 5-hydroxytryptamine in the physiological control of its central function?
    Grahame-Smith DG
    Adv Biochem Psychopharmacol; 1974; 10():83-91. PubMed ID: 4367772
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
    Deakin JF; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):201-9. PubMed ID: 708990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of brain monoamine and locomotor activity in rats.
    Foldes A; Costa E
    Biochem Pharmacol; 1975 Sep; 24(17):1617-21. PubMed ID: 1191320
    [No Abstract]   [Full Text] [Related]  

  • 16. Repeated chlorpromazine administration increases a behavioural response of rats to 5-hydroxytryptamine receptor stimulation.
    Green AR
    Br J Pharmacol; 1977 Feb; 59(2):367-71. PubMed ID: 264797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of diphenylhydantoin on brain 5-hydroxytryptamine metabolism and function.
    Green AR; Grahame-Smith DG
    Neuropharmacology; 1975 Feb; 14(2):107-13. PubMed ID: 1153078
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroleptic drugs block both the hyperactivity and the increase in caudate nucleus cyclic AMP concentration produced by the administration of tranylcypromine and L-dopa to rats.
    Heal DJ; Green AR; Bloomfield MR; Grahame-Smith DG
    Psychopharmacology (Berl); 1978 Apr; 57(2):193-7. PubMed ID: 26101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses of developing rats to L-tryptophan plus an MAOI-I. Monitoring changes in behaviour, brain 5-HT and tryptophan.
    Atterwill CK; Green AR
    Neuropharmacology; 1980 Apr; 19(4):325-35. PubMed ID: 7383278
    [No Abstract]   [Full Text] [Related]  

  • 20. Brain structures involved in the behavioral stimulant effect of central serotonin release.
    Vanderwolf CH; McLauchlin M; Dringenberg HC; Baker GB
    Brain Res; 1997 Oct; 772(1-2):121-34. PubMed ID: 9406964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.